miRagen To Present At The 2016 Wedbush PacGrow Healthcare Conference
BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a clinical-stage biopharmaceutical company developing innovative microRNA-based therapeutics, today announced its participation in the 2016 Wedbush PacGrow Healthcare Conference.
Conference Details:
The 2016 Wedbush PacGrow Healthcare Conference
Conference Details:
The 2016 Wedbush PacGrow Healthcare Conference